-
1
-
-
0020674832
-
Subjective side-effects of amitriptyline and lithium in affective disorders
-
Abou-Saleh M.T., Coppen A. Subjective side-effects of amitriptyline and lithium in affective disorders. Br. J. Psychiatry. 142:1983;391-397.
-
(1983)
Br. J. Psychiatry
, vol.142
, pp. 391-397
-
-
Abou-Saleh, M.T.1
Coppen, A.2
-
2
-
-
0022496109
-
The biology of folate in depression: Implications for nutritional hypotheses of the psychoses
-
Abou-Saleh M.T., Coppen A. The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J. Psychiatr. Res. 20:1986;91-101.
-
(1986)
J. Psychiatr. Res.
, vol.20
, pp. 91-101
-
-
Abou-Saleh, M.T.1
Coppen, A.2
-
4
-
-
0003852257
-
Treatment of Depression - Newer Pharmacotherapies
-
Agency for Health Care Policy and Research, March
-
Agency for Health Care Policy and Research, March, 1999. Treatment of Depression - Newer Pharmacotherapies. Summary, Evidence Report/Technology Assessment: Number 7 http://www.ahcpr.gov/clinic/deprsumm.htm.
-
(1999)
Summary, Evidence Report/Technology Assessment: Number 7
-
-
-
6
-
-
0027812240
-
Severity of depression and benzodiazepine co-medication in relationship to efficacy of antidepressants in acute trials. A meta-analysis of moclobemide trials
-
Angst J. Severity of depression and benzodiazepine co-medication in relationship to efficacy of antidepressants in acute trials. A meta-analysis of moclobemide trials. Human Psychopharmacol. 8:1993;404-407.
-
(1993)
Human Psychopharmacol.
, vol.8
, pp. 404-407
-
-
Angst, J.1
-
7
-
-
0025288848
-
Red cell folate concentrations in psychiatric patients
-
Carney M.W.P., Chary T.K.N., Laundy M., et al. Red cell folate concentrations in psychiatric patients. J. Affect. Disord. 19:1990;207-213.
-
(1990)
J. Affect. Disord.
, vol.19
, pp. 207-213
-
-
Carney, M.W.P.1
Chary, T.K.N.2
Laundy, M.3
-
9
-
-
0024509850
-
Depression and tetrahydrobiopterin: The folate connection
-
Coppen A., Swade C., Jones S.A., Armstrong R.A., Blair J.A., Leeming R.J. Depression and tetrahydrobiopterin: the folate connection. J. Affect. Disord. 16:1989;103-107.
-
(1989)
J. Affect. Disord.
, vol.16
, pp. 103-107
-
-
Coppen, A.1
Swade, C.2
Jones, S.A.3
Armstrong, R.A.4
Blair, J.A.5
Leeming, R.J.6
-
10
-
-
0032565616
-
Depressive symptoms and increased risk of stroke mortality over a 29-year period
-
Everson S.A., Roberts R.E., Goldberg D.E., Kaplan G.A. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch. Intern. Med. 158:1998;1133-1138.
-
(1998)
Arch. Intern. Med.
, vol.158
, pp. 1133-1138
-
-
Everson, S.A.1
Roberts, R.E.2
Goldberg, D.E.3
Kaplan, G.A.4
-
11
-
-
0030614878
-
Folate, vitamin B12, and homocysteine in major depressive disorder
-
Fava M., Borus J.S., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am. J. Psychiatry. 154:1997;426-428.
-
(1997)
Am. J. Psychiatry
, vol.154
, pp. 426-428
-
-
Fava, M.1
Borus, J.S.2
Alpert, J.E.3
Nierenberg, A.A.4
Rosenbaum, J.F.5
Bottiglieri, T.6
-
12
-
-
0031975288
-
Depression and the course of coronary artery disease
-
Glassman A.H., Shapiro P.A. Depression and the course of coronary artery disease. Am. J. Psychiatry. 55:1998;4-11.
-
(1998)
Am. J. Psychiatry
, vol.55
, pp. 4-11
-
-
Glassman, A.H.1
Shapiro, P.A.2
-
13
-
-
0025113543
-
Enhancement of recovery from psychiatric illness by methylfolate
-
Godfrey P.S., Toone B.K., Carney M.W., et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 336:1990;392-395.
-
(1990)
Lancet
, vol.336
, pp. 392-395
-
-
Godfrey, P.S.1
Toone, B.K.2
Carney, M.W.3
-
15
-
-
2242477014
-
Lowering blood homocysteine with folic acid based supplements: Meta analysis of randomised trials
-
Lowering blood homocysteine with folic acid based supplements: meta analysis of randomised trials. Br. Med. J. 316:1998;894-898.
-
(1998)
Br. Med. J.
, vol.316
, pp. 894-898
-
-
-
16
-
-
0032889343
-
Identification of cognitive impairment in the elderly. Homocysteine is an early marker
-
Lelimann M., Gottfries C.G., Regland B. Identification of cognitive impairment in the elderly. Homocysteine is an early marker. Dement. Geriatr. Cogn. Disord. 10:1999;12-20.
-
(1999)
Dement. Geriatr. Cogn. Disord.
, vol.10
, pp. 12-20
-
-
Lelimann, M.1
Gottfries, C.G.2
Regland, B.3
-
18
-
-
0030996001
-
Global mortality, disability, and the contribution of risk factors. Global Burden of Disease Study
-
Murray O., Lopez A.D. Global mortality, disability, and the contribution of risk factors. Global Burden of Disease Study. Lancet. 349:1997;1436-1442.
-
(1997)
Lancet
, vol.349
, pp. 1436-1442
-
-
Murray, O.1
Lopez, A.D.2
-
21
-
-
0029012953
-
History of depression as a risk factor for Alzheimer's disease
-
Speck C.E., Kukull W.A., Brenner D.E., et al. History of depression as a risk factor for Alzheimer's disease. Epidemiology. 6:1995;366-369.
-
(1995)
Epidemiology
, vol.6
, pp. 366-369
-
-
Speck, C.E.1
Kukull, W.A.2
Brenner, D.E.3
-
22
-
-
0032991749
-
Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives
-
Van der Griend R., Haas M.M., Biesma D.H., Duran M., Meuwissen W.A.T., Banga J.-D. Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives. Atherosclerosis. 143:1999;177-183.
-
(1999)
Atherosclerosis
, vol.143
, pp. 177-183
-
-
Van Der Griend, R.1
Haas, M.M.2
Biesma, D.H.3
Duran, M.4
Meuwissen, W.A.T.5
Banga, J.-D.6
|